BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 14979968)

  • 1. Acid reflux management: ENT perspective.
    Ahmad I; Batch AJ
    J Laryngol Otol; 2004 Jan; 118(1):25-30. PubMed ID: 14979968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voice disorders and gastroesophageal reflux.
    Sereg-Bahar M; Jansa R; Hocevar-Boltezar I
    Logoped Phoniatr Vocol; 2005; 30(3-4):120-4. PubMed ID: 16287651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients.
    Siupsinskiene N; Adamonis K; Toohill RJ; Sereika R
    J Laryngol Otol; 2008 Nov; 122(11):1206-12. PubMed ID: 18331659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians.
    Ahmed TF; Khandwala F; Abelson TI; Hicks DM; Richter JE; Milstein C; Vaezi MF
    Am J Gastroenterol; 2006 Mar; 101(3):470-8. PubMed ID: 16542282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
    Park W; Hicks DM; Khandwala F; Richter JE; Abelson TI; Milstein C; Vaezi MF
    Laryngoscope; 2005 Jul; 115(7):1230-8. PubMed ID: 15995512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Manifestations of gastroesophageal reflux in the otorhinolaryngology tract].
    Issing WJ; Gross M; Tauber S
    Laryngorhinootologie; 2001 Aug; 80(8):464-9. PubMed ID: 11552426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of 24-hour intraesophageal pH monitoring with 2 channels in the diagnosis of reflux-induced otolaryngologic disorders].
    Issing WJ; Tauber S; Folwaczny C; Reichel O
    Laryngorhinootologie; 2003 May; 82(5):347-52. PubMed ID: 12800080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Otolaryngologic manifestations of gastro-oesophageal reflux disease in Lagos.
    Somefun OA; Wanda CB; Adesanya AA; Thomas MO; Esan OO
    Niger Postgrad Med J; 2006 Sep; 13(3):225-9. PubMed ID: 17066111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis.
    Noordzij JP; Khidr A; Desper E; Meek RB; Reibel JF; Levine PA
    Laryngoscope; 2002 Dec; 112(12):2192-5. PubMed ID: 12461340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastroesophageal reflux involvement in ENT disorders].
    Drug VL; Cobzeanu D; Papaghiuc C; Ciochină P; Gogălniceanu P; Bugioianoun C; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):220-2. PubMed ID: 16607774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis.
    Williams RB; Szczesniak MM; Maclean JC; Brake HM; Cole IE; Cook IJ
    Am J Gastroenterol; 2004 May; 99(5):777-85. PubMed ID: 15128336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy.
    Qua CS; Wong CH; Gopala K; Goh KL
    Aliment Pharmacol Ther; 2007 Feb; 25(3):287-95. PubMed ID: 17269990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
    Wo JM; Grist WJ; Gussack G; Delgaudio JM; Waring JP
    Am J Gastroenterol; 1997 Dec; 92(12):2160-5. PubMed ID: 9399745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laryngeal disorders in patients with gastroesophageal reflux disease.
    Farrokhi F; Vaezi MF
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):181-7. PubMed ID: 17557046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should upper gastrointestinal endoscopy be part of the evaluation for supraesophageal symptoms of GERD?
    DeVault KR
    Am J Gastroenterol; 2004 Aug; 99(8):1427-9. PubMed ID: 15307854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-probe 24-hour ambulatory pH monitoring for diagnosis of laryngopharyngeal reflux.
    Issing WJ; Karkos PD; Perreas K; Folwaczny C; Reichel O
    J Laryngol Otol; 2004 Nov; 118(11):845-8. PubMed ID: 15638969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance with anti-reflux therapy in patients with otolaryngologic manifestations of gastroesophageal reflux disease.
    Giacchi RJ; Sullivan D; Rothstein SG
    Laryngoscope; 2000 Jan; 110(1):19-22. PubMed ID: 10646709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silent reflux: ex juvantibus criteria for diagnosis and treatment of laryngeal disorders.
    Monini S; Di Stadio A; Vestri A; Barbara M
    Acta Otolaryngol; 2006 Aug; 126(8):866-71. PubMed ID: 16846931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile reflux as possible risk factor in laryngopharyngeal inflammatory and neoplastic lesions.
    Galli J; Calò L; Agostino S; Cadoni G; Sergi B; Cianci R; Cammarota G
    Acta Otorhinolaryngol Ital; 2003 Oct; 23(5):377-82. PubMed ID: 15108488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The yield of upper gastrointestinal endoscopy in patients with suspected reflux-related chronic ear, nose, and throat symptoms.
    Poelmans J; Feenstra L; Demedts I; Rutgeerts P; Tack J
    Am J Gastroenterol; 2004 Aug; 99(8):1419-26. PubMed ID: 15307853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.